Viral Suppression Rates at 48 Weeks in People With HIV Starting Long-Acting Cabotegravir/Rilpivirine With Initial Viremia
HIV感染者在接受长效卡博特韦/利匹韦林治疗48周后,初始病毒血症患者的病毒抑制率
期刊:Clinical Infectious Diseases
影响因子:
doi:10.1093/cid/ciae500
Hickey, Matthew D; Gistand, Nathanael; Grochowski, Janet; Mayorga-Munoz, Francis; Imbert, Elizabeth; Szumowski, John D; Oskarsson, Jon; Shiels, Mary; Dilworth, Samantha; Appa, Ayesha; Havlir, Diane V; Gandhi, Monica; Christopoulos, Katerina